Generate Biomedicines Inc.

Last updated September 27, 2026

Organization details

Legal name
Generate Biomedicines Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Somerville
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
GENB
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0002100782
EIN
83-1630228

Board of directors

Chief executives

Michael Nally · Chief Executive Officer
Since February 2026

Board connections

8 of this board's directors also sit on 9 other boards. 4 are in the same sector.

Network of Generate Biomedicines Inc.'s board connections Moderna Inc. Moderna Inc. Alnylam Pharmaceuticals Inc. Alnylam Pharmaceutical... Alphabet Inc. Alphabet Inc. Bio-Techne Corp Bio-Techne Corp Foghorn Therapeutics Inc. Foghorn Therapeutics I... Illumina Inc. Illumina Inc. Lazard Inc. Lazard Inc. PPG Industries Inc. PPG Industries Inc. The Clorox Company The Clorox Company Frances Arnold Frances Arnold Jane L. Mendillo Jane L. Mendillo Marsha Fanucci Marsha Fanucci Michael Nally Michael Nally Noubar Afeyan Noubar Afeyan Paul Gray Parker Paul Gray Parker Rupert Vessey Rupert Vessey Stephane Bancel Stephane Bancel Generate Biomedicines Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$150,300,800
12 purchases by 5 insiders
Sold, last 12 months
$200,733
2 sales by 1 insider
Date Insider Transaction Shares Price Value
Oct 29, 2026 Frances Arnold Director Open-market sale −11,409 $16.19 $184,733
Sep 1, 2026 Frances Arnold Director Open-market sale −1,000 $16.00 $16,000
Mar 4, 2026 Michael Nally Director, Officer (Chief Executive Officer) Open-market purchase +20,000 $12.00 $240,000
Mar 2, 2026 Grous Beth Officer (Chief People Officer) Open-market purchase +300 $16.00 $4,800
Mar 2, 2026 Silvers Jason Officer (President & CFO) Open-market purchase +500 $16.00 $8,000
Mar 2, 2026 Noubar Afeyan Director, 10% owner Derivative conversion +12,723,940 — —
Mar 2, 2026 Michael Nally Director, Officer (Chief Executive Officer) Derivative conversion +658,327 — —
Mar 2, 2026 Stephane Bancel Director Derivative conversion +724,160 — —
Mar 2, 2026 Jane L. Mendillo Director Open-market purchase +1,500 $16.00 $24,000
Mar 2, 2026 Noubar Afeyan Director, 10% owner Derivative conversion +12,723,940 — —
Mar 2, 2026 Silvers Jason Officer (President & CFO) Open-market purchase +500 $16.00 $8,000
Mar 2, 2026 Noubar Afeyan Director, 10% owner Derivative conversion +13,702,224 — —
Mar 2, 2026 Noubar Afeyan Director, 10% owner Derivative conversion +13,702,224 — —
Mar 2, 2026 Silvers Jason Officer (President & CFO) Open-market purchase +1,000 $16.00 $16,000
Mar 2, 2026 Noubar Afeyan Director, 10% owner Derivative conversion +987,491 — —

Organizations in the same sector, closest in location and size first.

Questions about Generate Biomedicines Inc.

Who is the CEO of Generate Biomedicines Inc.?

Michael Nally has been Generate Biomedicines Inc.'s Chief Executive Officer since February 2026.

How many directors are on Generate Biomedicines Inc.'s board?

Generate Biomedicines Inc.'s board has 9 directors: Frances Arnold, Jane L. Mendillo, Marsha Fanucci, Michael Nally, Nancy A. Simonian, Noubar Afeyan, Paul Gray Parker, Rupert Vessey and Stephane Bancel.

Are Generate Biomedicines Inc. insiders buying or selling shares?

Over the last 12 months, Generate Biomedicines Inc. insiders bought $150.3 million of shares in 12 purchases and sold $200,733 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="generate-biomedicines-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.